Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effect of Screen time on Glycaemic control of Type 2 Diabetes patients during COVID-19 Outbreak: A Survey based Study

View ORCID ProfileSayak Roy, View ORCID ProfileKingshuk Bhattacharjee
doi: https://doi.org/10.1101/2020.09.09.20188961
Sayak Roy
1Medica Superspeciality Hospital, Kolkata, India
Roles: Consultant Physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sayak Roy
  • For correspondence: sayak.roy.123@gmail.com
Kingshuk Bhattacharjee
2Medwes Pvt LTD, Kolkata, Wb, India
Roles: Consultant Biostatistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kingshuk Bhattacharjee
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Decreased workout during coronavirus disease 2019 (COVID-19) is a serious issue for the patients with type 2 diabetes (T2DM), since their glycaemic control is very much related to that. COVID-19 has posed a severe health issue that is playing havoc on the aged patients with existing comorbidities. Studies have shown mixed reports of social media on T2DM, with some showing positive results due to increased use of apps and adherence to lifestyle, while others have shown adiposity and glycaemic control related to hours spent on-screen time in children. Data on adult T2DM patients’ screen time activity and prevailing glycosylated haemoglobin (HbA1c), fasting blood sugar (FBS) and, post-prandial blood sugar (PPBS) is sparse.

Aim To study the effect of screen-time spent on social media per day on glycaemic parameters of T2DM patients.

Materials and methods Data was collected for T2DM patients giving informed written consent and meeting a set of pre-specified inclusion criteria. Through two rounds of surveys done from May 15 to June 26, the authors collected the answers to a set of questionnaires from a total of 344 patients sent via email. Due to the non-availability of data from a few patients, a total of 229 patients’ data were finally analyzed. SPSS software version V21 ® was used to perform Binary logistic regression for calculating the odds ratio (OR) of the categorical variables. The outcomes, looked for in the analysis, were poor control of glycaemic parameters like HbA1c (defined by >7%), FBS (defined by >150 mg/dL) and, PPBS (defined by >200 mg/dL) and the exposure variables were Screen time spent by the person per day for all the three glycaemic parameters and, doctor’s visit and, daily exercise for HbA1c outcome.

Results A total of 173 patients had a screen time (henceforth, it means time spent on social media) of less than 2 hours/day in the study sample. Among the 173 patients, 73 (42.2%) had achieved HbA1c less than 7%, whereas the remaining 100 (57.8%) had HbA1c more than 7%. On the other hand, 56 patients had a screen time of more than 2 hours, of which 44 (72.73%) had HbA1c more than 7%. Among the 173 patients, only 89 (51.44%) had an FBS value of more than 150 mg/dL as compared to 46 (82.12%) with a screen time of more than 2 hours. Out of these 173 patients, only 43 (24.86%) had a PPBS value of more than 200 mg/dL as compared to 41 (73.21%) with a screen time of more than 2 hours. It was found that the odds of having a poor glycaemic control as per HbA1c, FBS and PPBS is 2.67 times higher (95%CI: 1.91-6.95), 4.34 times higher (95%CI: 1.52-4.76) and, 8.26 times higher (95%CI: 4.26-11.83) in the cohort with a screen time of more than 2 hours as compared to the cohort with a screen time of less than 2 hours, respectively.

Conclusion There seems to be an increased risk of uncontrolled glycaemic indices with increased screen time and, decreased work out. This is a small study and the findings need to be corroborated with larger sample size.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The local ethical committee, Remedy Clinic Study Group, approved the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflicts of Interest: None

  • Funding: Nil

  • Ethical approval part was mentioned in two places by mistake and this has been corrected. It has been corrected now and, it is mentioned only in Materials and methods section.

Data Availability

Available on request with the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 10, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Screen time on Glycaemic control of Type 2 Diabetes patients during COVID-19 Outbreak: A Survey based Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Screen time on Glycaemic control of Type 2 Diabetes patients during COVID-19 Outbreak: A Survey based Study
Sayak Roy, Kingshuk Bhattacharjee
medRxiv 2020.09.09.20188961; doi: https://doi.org/10.1101/2020.09.09.20188961
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Effect of Screen time on Glycaemic control of Type 2 Diabetes patients during COVID-19 Outbreak: A Survey based Study
Sayak Roy, Kingshuk Bhattacharjee
medRxiv 2020.09.09.20188961; doi: https://doi.org/10.1101/2020.09.09.20188961

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8556)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1747)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10290)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3834)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)